The Keto HDAC Myth — How One Paper Misled Millions for a Decade
- A 2013 Science paper claimed beta-hydroxybutyrate (BHB), the primary ketone body produced during ketosis, was a potent histone deacetylase (HDAC) inhibitor with powerful epigenetic benefits — this claim became the foundation of the keto movement's health narrative
- A devastating 2019 head-to-head comparison in Scientific Reports found that BHB shows no detectable HDAC inhibition in vitro or in vivo, while butyrate (a different molecule produced by gut bacteria) demonstrates robust HDAC-inhibiting activity
- The bitter irony: ketogenic diets actually reduce colonic butyrate production by depleting fiber intake and diminishing butyrate-producing gut bacteria — the very diet designed to boost the "HDAC-inhibiting ketone" may be depleting the actual HDAC inhibitor
- While BHB has legitimate benefits as an alternative fuel source and GPR109A receptor activator, the widespread claim that ketosis provides "epigenetic therapy" through HDAC inhibition appears to be scientifically unfounded
You May Also Like
Let me bore you to sleep
Jason Newland

Get Sleepy: Sleep meditation and stories
Slumber Studios

Let me bore you to sleep - Jason Newland
Jason Newland

Hypnosis for sleeping deeply (Jason Newland)
Jason Newland

Find Your Daily Calm
Sel Gaston

Your Life Nutrition Podcast
Brittany Liberatore, RDN

Somatic Movement & Mindset
Heidi Hadley

Good Thinking: Positive Affirmations
Just Curious Media

The Omni Dental & Medspa Podcast
Dr. Bilus Poles

Por el Placer de Vivir con el Dr. Cesar Lozano
Uforia Podcasts
Community discussion